A cross-over, double-blind comparison of the NAL-NL1 and the DSL v4.1 prescriptions for children with mild to moderately severe hearing loss.
about
A comparison of NAL and DSL prescriptive methods for paediatric hearing-aid fitting: predicted speech intelligibility and loudness.A randomized controlled comparison of NAL and DSL prescriptions for young children: hearing-aid characteristics and performance outcomes at three years of ageNAL-NL2 empirical adjustments.Speech perception and localisation with SCORE bimodal: a loudness normalisation strategy for combined cochlear implant and hearing aid stimulation.Parents' evaluation of aural/oral performance of children (PEACH) scale in the Malay language: data for normal-hearing children.Questionnaires on satisfaction of amplification in children: a systematic review.Children's speech perception and loudness ratings when fitted with hearing aids using the DSL v.4.1 and the NAL-NL1 prescriptions.Evaluation of the NAL-NL1 and DSL v4.1 prescriptions for children: Preference in real world use.Introduction to the longitudinal outcomes of children with hearing impairment (LOCHI) study: background, design, sample characteristics.The relationship between cortical auditory evoked potential (CAEP) detection and estimated audibility in infants with sensorineural hearing loss.Evaluation of real-world preferences and performance of hearing aids fitted according to the NAL-NL1 and DSL v5 procedures in children with moderately severe to profound hearing loss.Hearing aid fitting and developmental outcomes of children fit according to either the NAL or DSL prescription: fit-to-target, audibility, speech and language abilities.Evaluation of the NAL-NL1 and the DSL v.4.1 prescriptions for children: Paired-comparison intelligibility judgments and functional performance ratings.Prescribed real-ear and achieved real-life differences in children's hearing aids adjusted according to the NAL-NL1 and the DSL v.4.1 prescriptions.Special issue on paediatric amplification.
P2860
Q30424085-364766F9-7A9A-49EE-A800-BCA3AF60A614Q30424097-6C529F62-664A-4293-AADA-0CE234D81E5FQ30424774-D0C142FF-2984-4A33-AC1B-8A5D04740662Q30462073-1CB4EC53-8948-43AC-89AC-808F5AC484C2Q34103821-6BC0D80D-7CAA-49C4-A3F5-DA4DEE87EBB1Q35120334-9ABF6AA6-A6EA-45FB-9B7D-F25778FEAE43Q39916985-F9AA1427-C9CA-4EA0-BC21-78351856BD54Q39916991-F64BF1CE-D3A8-45D4-B1D3-AF5101B34991Q43556297-DAD9A7B3-2DBB-4789-9E21-C27A9B3E8891Q48416494-8AA96032-AE4A-482B-A269-5D9230F72323Q48964404-96188912-8032-40A5-A0E0-B9D7D7743513Q50305465-8DA392EB-16D4-41E1-8022-B290D0B63CD9Q50439568-A029A518-5DD7-4B5F-888F-E5B613969F05Q50439577-8195E24B-EC51-418D-865C-2E651DBDD4DCQ50439580-E035D612-E6FC-4504-BC50-ABF0E992BFA4
P2860
A cross-over, double-blind comparison of the NAL-NL1 and the DSL v4.1 prescriptions for children with mild to moderately severe hearing loss.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A cross-over, double-blind com ...... oderately severe hearing loss.
@en
A cross-over, double-blind com ...... oderately severe hearing loss.
@nl
type
label
A cross-over, double-blind com ...... oderately severe hearing loss.
@en
A cross-over, double-blind com ...... oderately severe hearing loss.
@nl
prefLabel
A cross-over, double-blind com ...... oderately severe hearing loss.
@en
A cross-over, double-blind com ...... oderately severe hearing loss.
@nl
P2860
P1476
A cross-over, double-blind com ...... oderately severe hearing loss.
@en
P2093
Richard Seewald
Susan D Scollie
P2860
P356
10.3109/14992020903148020
P478
49 Suppl 1
P577
2010-01-01T00:00:00Z